Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells

被引：67

作者：

Chuu, Chih-Pin ^{[1
]}

Chen, Rou-Yu ^{[1
]}

Kokontis, John M. ^{[1
]}

Hiipakka, Richard A. ^{[1
]}

Liao, Shutsung ^{[1
]}

机构：

[1] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA

来源：

CANCER LETTERS | 2009年 / 275卷 / 01期

关键词：

Prostate cancer; LNCaP; EGCG; PSA; Androgen receptor; TEA EPIGALLOCATECHIN GALLATE; GREEN TEA; ATHYMIC MICE; TUMOR-GROWTH; REGULATED ACTIVITY; CARCINOMA-CELLS; CYCLE ARREST; TRAMP MICE; INHIBITION; DEPRIVATION;

D O I：

10.1016/j.canlet.2008.10.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The green tea polyphenol, (-)-epigallocatechin-3-gallate (EGCG), inhibits the development and progression of prostate cancer in TRAMP mice and in men. We examined the effects of EGCG on LNCaP human prostate cancer sublines 104-S, 104-R1 and R1Ad representing different progression stages of prostate cancer. EGCG suppressed cell proliferation, prostate specific antigen (PSA) expression, and AR transcriptional activity in the different LNCaP sublines. Intraperitoneal administration of EGCG also suppressed the growth of relapsing R1Ad tumors and decreased tumor-derived serum PSA. Effects of EGCG on tumor PSA expression have the potential to affect accurate monitoring of patient tumor burden by serum PSA measurements. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：86 / 92

页数：7

共 50 条

[41] Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
Liu, Tiancheng
Wu, Lisa Y.
Fulton, Melody D.
Johnson, Jacqueline M.
Berkman, Clifford E.
INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (06) : 2087 - 2092
[42] Interaction of IGF signaling and the androgen receptor in prostate cancer progression
Wu, Jennifer D.
Haugk, Kathy
Woodke, Libby
Nelson, Peter
Coleman, Ilsa
Plymate, Stephen R.
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (02) : 392 - 401
[43] Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells
Sanchez-Gonzalez, Claudia
Ciudad, Carlos J.
Noe, Veronique
Izquierdo-Pulido, Maria
FOOD & FUNCTION, 2014, 5 (11) : 2922 - 2930
[44] LUTEOLIN AFFECTS CELL PROLIFERTATION, CELL INVASION AND PROSTATE-SPECIFIC ANTIGEN EXPRESSION BY DYREGULATION OF PROSTATE-DERIVED ETS FACTOR AND ANDROGEN RECEPTOR EXPRESSION IN PROSTATE CARCINOMA LNCAP CELLS
Tsui, Ke-Hung, Sr.
Juang, Horng-Heng, Sr.
JOURNAL OF UROLOGY, 2009, 181 (04): : 396 - 396
[45] Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells
Mukherjee, Sushovita
Siddiqui, Mohammad Adnan
Dayal, Shubham
Ayoub, Yasmine Zakaria
Malathi, Krishnamurthy
JOURNAL OF INFLAMMATION RESEARCH, 2014, 7 : 89 - 101
[46] Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells
Sánchez, MG
Sánchez, AM
Ruiz-Llorente, L
Díaz-Laviada, L
FEBS LETTERS, 2003, 555 (03) : 561 - 566
[47] Epigallocatechin-3-gallate inhibits endothelin A receptor signaling pathway inovarian carcinoma cells
不详
CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (07) : 655 - 656
[48] Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells
Zhu, YS
Cai, LQ
You, XK
Cordero, JJ
Huang, Y
Imperato-McGinley, J
JOURNAL OF ANDROLOGY, 2003, 24 (05): : 681 - 687
[49] Progression of LNCaP human prostate carcinoma cells: Androgen receptor activity and c-myc gene expression
Kokontis, JM
Hay, N
Hiipakka, RA
Liao, SS
HORMONAL CARCINOGENESIS II, 1996, : 260 - 268
[50] Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk
Salinas, CA
Austin, MA
Ostrander, EO
Stanford, JL
PROSTATE, 2005, 65 (01): : 58 - 65

← 1 2 3 4 5 →